000 | 01941 a2200505 4500 | ||
---|---|---|---|
005 | 20250516055550.0 | ||
264 | 0 | _c20120222 | |
008 | 201202s 0 0 eng d | ||
022 | _a1522-1504 | ||
024 | 7 |
_a10.1152/ajplung.00041.2011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Visser, Yvonne P | |
245 | 0 | 0 |
_aPhosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Lung cellular and molecular physiology _cJan 2012 |
||
300 |
_aL56-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aBenzamides _xpharmacology |
650 | 0 | 4 |
_aBronchopulmonary Dysplasia _xdrug therapy |
650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 4 _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 |
_aHeart Injuries _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperoxia _xdrug therapy |
650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
650 | 0 | 4 |
_aHypertrophy, Right Ventricular _xdrug therapy |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aOxygen _xpharmacology |
650 | 0 | 4 |
_aPhosphodiesterase 4 Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPulmonary Alveoli _xdrug effects |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRats |
700 | 1 | _aWalther, Frans J | |
700 | 1 | _aLaghmani, El Houari | |
700 | 1 | _aSteendijk, Paul | |
700 | 1 | _aMiddeldorp, Maaike | |
700 | 1 | _avan der Laarse, Arnoud | |
700 | 1 | _aWagenaar, Gerry T M | |
773 | 0 |
_tAmerican journal of physiology. Lung cellular and molecular physiology _gvol. 302 _gno. 1 _gp. L56-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajplung.00041.2011 _zAvailable from publisher's website |
999 |
_c21186640 _d21186640 |